Compound ID | 361
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Cell wall inhibitors; active against resistant Gram positive bacteria such as MRSA with low murine acute toxicity |
| Institute where first reported: | Bristol-Myers Squibb |
| Year first mentioned: | 2000 |
| Development status: | Inactive |
| External links: | |
| Citation: |